| Literature DB >> 31867855 |
Marilena Castelli1, Danilo Piobbico1, Martina Chiacchiaretta1, Cinzia Brunacci1, Stefania Pieroni1, Daniela Bartoli1, Marco Gargaro1, Francesca Fallarino1,2, Paolo Puccetti1,2, Silvia Soddu3, Maria Agnese Della-Fazia1, Giuseppe Servillo1,2.
Abstract
Apoptotic signalling by p53 occurs at both transcriptional and non-transcriptional levels, as p53 may act as a direct apoptogenic stimulus via activation of the intrinsic mitochondrial pathway. HOPS is a highly conserved, ubiquitously expressed shuttling protein with an ubiquitin-like domain. We generated Hops-/- mice and observed that they are viable with no apparent phenotypic defects. However, when treated with chemotherapeutic agents, Hops-/- mice display a significant reduction in apoptosis, suggesting an impaired ability to respond to genotoxic stressors. We show that HOPS acts as a regulator of cytoplasmic p53 levels and function. By binding p53, HOPS inhibits p53 proteasomal degradation and favours p53 recruitment to mitochondria and apoptosis induction. By interfering with importin α, HOPS further increases p53 cytoplasmic levels. Thus, HOPS promotes the p53-dependent mitochondrial apoptosis pathway by preserving cytoplasmic p53 from both degradation and nuclear uptake.Entities:
Keywords: zzm321990HOPSzzm321990; TMUB1; apoptosis; mitochondria; p53; ubiquitin like
Mesh:
Substances:
Year: 2019 PMID: 31867855 PMCID: PMC7001502 DOI: 10.15252/embr.201948073
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807